What Angita Pharmaceuticals offers

Angita Pharmaceuticals develops novel, patent-protected drug development candidates with strategic focus on CNS indications and those in which the CNS plays a clear regulatory function.

We in-license novel IP from academia and adopt a flexible licensing model giving the inventor the opportunity to participate in the drug discovery projects. Other projects in our discovery pipeline come from in-house research activities and via joint projects with collaborative partners.

To ensure focus on our discovery projects, development candidates will be out-licensed.

In-licensing

Angita Pharmaceuticals is actively seeking in-licensing partnerships. We welcome contacts from academic institutions, pharmaceutical and biotechnology companies with project ideas that:   

• Have a strong intellectual property position
• Address an unmet medical need
• Have a basic preclinical proof of concept 

Partnering

We are happy to discuss partnering or out-licensing of our projects at any time during the drug discovery process. Pharmaceutical or Biotechnology Companies are welcome to contact us to discuss mutually interesting opportunities.

Contact Sandra Hogg, Chief Executive Officer

shogg@angitapharma.com

Affiliates & Sponsors